WeightWatchers Moves Into the Ozempic Market With Telehealth Deal - WSJ
4.8 (143) · € 24.50 · En Stock
WeightWatchers buys health platform Sequence, facilitating access to Ozempic and Wegovy
WeightWatchers Launches New Behavior Change Program Designed to Support the Unique Needs of Individuals on GLP-1 Medications
The Disruptive Power of Weight Loss Drugs Is Being Felt Beyond Pharma - The New York Times
Health Startups Offer Diabetes Drugs Like Ozempic for Weight Loss With Little Oversight - WSJ
Oprah, Ozempic and Apologies: WeightWatchers' New Formula - WSJ
Noom Picks New CEO as It Moves Into Market for Ozempic - WSJ
Diet Company Medifast, Once an Ozempic Skeptic, Embraces Weight Loss Drugs With LifeMD Telehealth Deal - WSJ
WeightWatchers Gets a Makeover With Obesity-Drug Business - WSJ
Ozempic Can Make You Thin, Not Necessarily Healthy - WSJ
